MANKIND PHRAMA IPO
Sekhmet, Nirma in fray for Glenmark's API businessSekhmet Pharmaventures and Nirma Group are in competition to acquire Glenmark Life Sciences (GLS), the 82.85% subsidiary of Glenmark Pharma...
Macquarie initiates coverage on Mankind Pharma, sees 30% upsideMankind Pharma derives 98% of its revenue from the domestic pharma market. Within its domestic business, 90% of its revenue comes from pres...
- Load More